Global Contrast Media Market Analysis Report 2022-2030 by Modality (MRI, X-ray/CT, Ultrasound), Product Type (Iodinated, Gadolinium-based), & Application (Cardiovascular Disorders) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Contrast Media Market Size, Share & Trends Analysis Report by Modality (MRI, X-ray/CT, Ultrasound), by Product Type (Iodinated, Gadolinium-based), by Application (Cardiovascular Disorders), by Region, and Segment Forecasts, 2022-2030" report has been added to ResearchAndMarkets.com's offering.

The global contrast media market size is anticipated to reach USD 7.57 billion by 2030. The market is expected to expand at a CAGR of 3.33% from 2022 to 2030.

The rising prevalence of chronic diseases is fueling the demand for diagnostic imaging treatments, which is propelling the market forward. Imaging studies, such as MRI, have become an important aspect of most disease diagnoses, and the widespread use of imaging technologies in healthcare has boosted the demand for contrast media globally.

Chronic diseases like cancer and diabetes are quickly becoming a major public health concern and are among the leading causes of mortality worldwide, necessitating the development of early detection techniques and effective treatment alternatives. As a result, one of the key drivers of imaging tests and contrast agents is the rising prevalence of complicated comorbidities and long-term disorders, thus boosting the market worldwide.

Due to fewer patient visits to hospitals, the COVID-19 pandemic had a detrimental influence on the global contrast media market. The number of imaging cases in several radiology departments dropped dramatically. Many countries worldwide have begun to rebuild their economy, but it will take time for contrast media utilization rates to return to pre-pandemic levels.

Furthermore, with the launch of COVID-19 vaccines and the relaxation of restrictions, raw material imports and exports have begun, indicating that the market will develop at a high rate throughout the projection period.

Contrast Media Market Report Highlights

• On the basis of modality, the X-ray/Computed Tomography segment held the largest market share in 2021, accounting for 69.53%. Wide acceptance and cost-efficiency of the X-ray/CT modality boost the adoption of contrast agents used for this modality.
• Based on type, the iodinated contrast media segment held the largest market share in 2021, accounting for 66.61%. This is due to their excellent radio-opacity and low toxicity than other agents.
• Based on application, the neurological disorders segment dominated the market and held the largest revenue share of nearly 29.45%. Diagnostic evaluation of CNS for neurological disorders boosts the adoption of MRI contrast agents, as they provide better images of neural structures than CT.

Key Topics Covered:

Chapter 1 Methodology and Scope

Chapter 2 Executive Summary

2.1 Market Outlook

2.2 Segment Outlook

2.3 Competitive Insights

Chapter 3 Contrast Media Market Variables, Trends & Scope

3.1 Market Lineage Outlook

3.1.1 Parent Market Outlook

3.1.2 Ancillary Market Outlook

3.2 Penetration & Growth Prospect Mapping

3.3 User Perspective Analysis

3.3.1 Consumer Behavior Analysis

3.3.2 Market Influencer Analysis

3.4 List Of Key End Users

3.5 Market Dynamics

3.5.1 Market Driver Analysis

3.5.1.1 Increasing Prevalence Of Long-Term Diseases and Complex Comorbidities

3.5.1.2 Technological Advancements

3.5.1.3 Label Expansions

3.5.2 Market Restraints Analysis

3.5.2.1 Rising Concern About Mri Gadolinium Agents Retained In Brain

3.6 Contrast Media : Market Analysis Tools

3.6.1 Industry Analysis-Porter's

3.6.2 Swot Analysis, by Pest

3.7 Impact Of Covid-19 On Market

Chapter 4 Contrast Media Market: Segment Analysis, by Modality, 2017-2030 (USD Million)

4.1 Definition and Scope

4.2 Modality Market Share Analysis, 2021 & 2030

4.3 Segment Dashboard

4.4 Global Contrast Media Market, by Modality, 2017 To 2030

4.5 Market Size & Forecasts and Trend Analyses, 2017 To 2030

4.5.1 X-Ray/Ct

4.5.2 Mri

4.5.3 Ultrasound

Chapter 5 Contrast Media Market: Segment Analysis, by Product, Type 2017-2030 (USD Million)

5.1 Definition and Scope

5.2 Product Type Market Share Analysis, 2021 & 2030

5.3 Segment Dashboard

5.4 Global Contrast Media Market, by Product Type, 2017 To 2030

5.5 Market Size & Forecasts and Trend Analyses, 2017 To 2030

5.5.1 Iodinated

5.5.2 Barium-Based

5.5.3 Gadolinium-Based

5.5.4 Microbubble

Chapter 6 Contrast Media Market: Segment Analysis, by Application, 2017-2030 (USD Million)

6.1 Definition and Scope

6.2 Application Market Share Analysis, 2021 & 2030

6.3 Segment Dashboard

6.4 Global Contrast Media Market, by Application, 2017 To 2030

6.5 Market Size & Forecasts and Trend Analyses, 2017 To 2030

6.5.1 Cardiovascular Disorders

6.5.2 Neurological Disorders

6.5.3 Gastrointestinal Disorders

6.5.4 Cancer

6.5.5 Nephrological Disorders

6.5.6 Musculoskeletal Disorders

6.5.7 Others

Chapter 7 Contrast Media Market: Regional Market Analysis, by Modality, by Product Type, and by Application, 2017-2030 (USD Million)

7.1 Definition & Scope

7.2 Regional Market Share Analysis, 2021 & 2030

7.3 Regional Market Dashboard

7.4 Regional Market Snapshot

7.5 Market Size, & Forecasts, Volume and Trend Analysis, 2021 To 2030

Chapter 8 Contrast Media Market-Competitive Analysis

8.1 Recent Developments & Impact Analysis, by Key Market Participants

8.2 Company Categorization

8.2.1 Innovators

8.2.2 Market Leaders

8.3 Vendor Landscape

8.3.1 Key Company Market Share Analysis, 2021

8.3.2 Major Deals and Strategic Alliances

8.3.2.1 New Product Launch

8.3.3 Market Entry Strategies

8.4 Company Profiles

• Bayer AG
• General Electric Company
• Guerbet
• Lantheus Medical Imaging, Inc.
• Bracco Diagnostic, Inc.
• nano Therapeutics Pvt. Ltd.
• iMAX
• Trivitron Healthcare

For more information about this report visit https://www.researchandmarkets.com/r/g79anr